109 related articles for article (PubMed ID: 38844390)
1. COVID-19 profiles in general practice: a latent class analysis.
Ferrat E; Mirat W; Boutin E; Maroto E; Brossier S; Hoonakker JD; Audureau E; Phan TT; Bastuji-Garin S
BMJ Open; 2024 Jun; 14(6):e080393. PubMed ID: 38844390
[TBL] [Abstract][Full Text] [Related]
2. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Horn SRA; Van den Bruel A;
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013665. PubMed ID: 33620086
[TBL] [Abstract][Full Text] [Related]
3. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Tans A; Janssens S; Wickramasinghe D; Lannoy V; Horn SRA; Van den Bruel A;
Cochrane Database Syst Rev; 2022 May; 5(5):CD013665. PubMed ID: 35593186
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of hyposmia and hypogeusia in 390 COVID-19 hospitalized patients and outpatients: a cross-sectional study.
Nouchi A; Chastang J; Miyara M; Lejeune J; Soares A; Ibanez G; Saadoun D; Morélot-Panzini C; Similowski T; Amoura Z; Boddaert J; Caumes E; Bleibtreu A; Lorenzo A; Tubach F; Pourcher V
Eur J Clin Microbiol Infect Dis; 2021 Apr; 40(4):691-697. PubMed ID: 33033955
[TBL] [Abstract][Full Text] [Related]
5. Broad-based SARS-CoV-2 testing program for healthcare workers in a primary care hospital in France.
Chas J; Nadal M; Siguier M; Fajac A; Denis M; Morand-Joubert L; Pialoux G
Infect Dis Now; 2021 Sep; 51(6):556-559. PubMed ID: 34000458
[TBL] [Abstract][Full Text] [Related]
6. Follow-up of adults with noncritical COVID-19 two months after symptom onset.
Carvalho-Schneider C; Laurent E; Lemaignen A; Beaufils E; Bourbao-Tournois C; Laribi S; Flament T; Ferreira-Maldent N; Bruyère F; Stefic K; Gaudy-Graffin C; Grammatico-Guillon L; Bernard L
Clin Microbiol Infect; 2021 Feb; 27(2):258-263. PubMed ID: 33031948
[TBL] [Abstract][Full Text] [Related]
7. Anosmia, ageusia, and other COVID-19-like symptoms in association with a positive SARS-CoV-2 test, across six national digital surveillance platforms: an observational study.
Sudre CH; Keshet A; Graham MS; Joshi AD; Shilo S; Rossman H; Murray B; Molteni E; Klaser K; Canas LD; Antonelli M; Nguyen LH; Drew DA; Modat M; Pujol JC; Ganesh S; Wolf J; Meir T; Chan AT; Steves CJ; Spector TD; Brownstein JS; Segal E; Ourselin S; Astley CM
Lancet Digit Health; 2021 Sep; 3(9):e577-e586. PubMed ID: 34305035
[TBL] [Abstract][Full Text] [Related]
8. Solitary Anosmia/Ageusia in Prison: Results From a COVID-19 Cluster.
Gwathney JK
J Correct Health Care; 2021 Mar; 27(1):8-10. PubMed ID: 34232758
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and characteristics of persistent symptoms after non-severe COVID-19: a prospective cohort study.
Armange L; Bénézit F; Picard L; Pronier C; Guillot S; Lentz PA; Carré F; Tattevin P; Revest M
Eur J Clin Microbiol Infect Dis; 2021 Nov; 40(11):2421-2425. PubMed ID: 33893570
[TBL] [Abstract][Full Text] [Related]
10. Course of disease and risk factors for hospitalization in outpatients with a SARS-CoV-2 infection.
Schäfer E; Scheer C; Saljé K; Fritz A; Kohlmann T; Hübner NO; Napp M; Fiedler-Lacombe L; Stahl D; Rauch B; Nauck M; Völker U; Felix S; Lucchese G; Flöel A; Engeli S; Hoffmann W; Hahnenkamp K; Tzvetkov MV
Sci Rep; 2022 May; 12(1):7249. PubMed ID: 35508524
[TBL] [Abstract][Full Text] [Related]
11. The importance of anosmia, ageusia and age in community presentation of symptomatic and asymptomatic SARS-CoV-2 infection in Louisiana, USA; a cross-sectional prevalence study.
Feehan AK; Fort D; Velasco C; Burton JH; Garcia-Diaz J; Price-Haywood EG; Sapp E; Pevey D; Seoane L
Clin Microbiol Infect; 2021 Apr; 27(4):633.e9-633.e16. PubMed ID: 33421576
[TBL] [Abstract][Full Text] [Related]
12. New-onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2 infection.
Patel A; Charani E; Ariyanayagam D; Abdulaal A; Denny SJ; Mughal N; Moore LSP
Clin Microbiol Infect; 2020 Sep; 26(9):1236-1241. PubMed ID: 32502645
[TBL] [Abstract][Full Text] [Related]
13. Symptom profiles and their risk factors in patients with post-COVID-19 condition: a Dutch longitudinal cohort study.
van Zon SKR; Ballering AV; Brouwer S; Rosmalen JGM;
Eur J Public Health; 2023 Dec; 33(6):1163-1170. PubMed ID: 37608757
[TBL] [Abstract][Full Text] [Related]
14. Clinical features and natural history of the first 2073 suspected COVID-19 cases in the Corona São Caetano primary care programme: a prospective cohort study.
Leal FE; Mendes-Correa MC; Buss LF; Costa SF; Bizario JCS; de Souza SRP; Thomaz O; Tozetto-Mendoza TR; Villas-Boas LS; de Oliveira-da Silva LC; Grespan RMZ; Capuani L; Buccheri R; Domingues H; Alexander N; Mayaud P; Sabino EC
BMJ Open; 2021 Jan; 11(1):e042745. PubMed ID: 33436471
[TBL] [Abstract][Full Text] [Related]
15. Headache, anosmia, ageusia and other neurological symptoms in COVID-19: a cross-sectional study.
Sampaio Rocha-Filho PA; Albuquerque PM; Carvalho LCLS; Dandara Pereira Gama M; Magalhães JE
J Headache Pain; 2022 Jan; 23(1):2. PubMed ID: 34979899
[TBL] [Abstract][Full Text] [Related]
16. Investigation on the Factors Associated with the Persistence of Anosmia and Ageusia in Saudi COVID-19 Patients.
Algahtani SN; Alzarroug AF; Alghamdi HK; Algahtani HK; Alsywina NB; Bin Abdulrahman KA
Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162068
[TBL] [Abstract][Full Text] [Related]
17. Initial characteristics and course of disease in patients with suspected COVID-19 managed in general practice: a prospective, multicentre cohort study.
Phan TT; Mirat W; Brossier S; Boutin E; Fabre J; Hoonakker JD; Bastuji-Garin S; Renard V; Ferrat E
BMJ Open; 2023 May; 13(5):e068424. PubMed ID: 37225268
[TBL] [Abstract][Full Text] [Related]
18. Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.
Dixon BE; Wools-Kaloustian K; Fadel WF; Duszynski TJ; Yiannoutsos C; Halverson PK; Menachemi N
medRxiv; 2020 Oct; ():. PubMed ID: 33106813
[TBL] [Abstract][Full Text] [Related]
19. Headache associated with COVID-19: Frequency, characteristics and association with anosmia and ageusia.
Rocha-Filho PAS; Magalhães JE
Cephalalgia; 2020 Nov; 40(13):1443-1451. PubMed ID: 33146035
[TBL] [Abstract][Full Text] [Related]
20. Smell and Taste Dysfunction in Pediatric Patients With SARS-CoV-2 Infection.
Púa Torrejón RC; Ordoño Saiz MV; González Alguacil E; Furones García M; Cantarín Extremera V; Ruiz Falcó ML; Soto Insuga V
Pediatr Neurol; 2022 Nov; 136():28-33. PubMed ID: 36084419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
